<DOC>
	<DOCNO>NCT02407106</DOCNO>
	<brief_summary>The purpose study determine whether daily treatment Streptococcus Salivarius BLIS K-12 prevents streptococcal throat infection child episode rheumatic fever .</brief_summary>
	<brief_title>Efficacy BLIS K12 Preventive Measure Rheumatic Children</brief_title>
	<detailed_description>Children diagnose Rheumatic fever currently give preventive streptococcal treatment either monthly IM ( intramuscular injection ) Penicillin daily oral Penicillin . This preventive treatment recommend year child 20 old even later . The compliance rate treatment decline significantly time ( injection painful ) even good adherence prevention complete . In last year new product license `` BLIS K-12 '' develop approve FDA GRAS ( generally recognize safe ) status 2011 . This probiotic treatment prevents pathogenic Strep A adhere throat child thus prevent infection . This kind prevention well long run patient surrounding , It well tolerate , effective even dose skipped miss painful tasty child . So investigators assumption give product child instead Penicillin either orally intramuscularlly well tolerate thus give good protection profile much less side effect . The investigator give BLIS K-12 child trial daily basis 6 autumn-winter month instead Penicillin monitor child monthly throat swab . The investigator also obtain Anti Streptolysin blood test end period participant evaluate possible Strep encounter .</detailed_description>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Rheumatic Fever</mesh_term>
	<criteria>Rheumatic heart disease recommend strep prophylaxis less one year first diagnosis refusal take tablet</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>BLIS K12</keyword>
	<keyword>streptococcus</keyword>
</DOC>